Use of ceftaroline in the management of vertebral osteomyelitis case report

Hadeel Zainah, Marwa Hammoud, Jose Antonio Vazquez

Research output: Contribution to journalArticle

3 Scopus citations


Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.

Original languageEnglish (US)
Pages (from-to)269-271
Number of pages3
JournalInfectious Diseases in Clinical Practice
Issue number4
Publication statusPublished - 2013
Externally publishedYes



  • Ceftaroline
  • Osteomyelitis
  • Staphylococcus aureus

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this